Search

everythinglearnresearchcommunity

for

Search:↓

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

RET mutation is important in familial medullary thyroid carcinoma, and BRAF mutation in papillary thyroid carcinoma is linked to more aggressive cancer and higher death rates.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

CEC levels may be a useful marker for predicting prostate cancer progression.

Hair follicles have a more inactive cell cycle than other skin cells, which may help develop targeted therapies for skin diseases and cancer.

Protein microarrays are highly sensitive tools useful for disease diagnosis and studying proteins.

Porocarcinoma generally has low rates of recurrence, spread to lymph nodes, and death.

More research is needed on better diagnostics, survivorship, and the impact of genetic mutations in lung cancer.

Reducing SOX2 in colorectal cancer cells decreases tumor growth and self-renewal.

Nanozymes show promise for effective and safe cancer treatment.

The platform effectively grows lung cancer cell spheroids for drug testing.

Combining genetic and physical data improves diagnosis and treatment for early-onset monogenic diabetes.

Enhancers and super-enhancers are key in controlling specific gene activity and can play a role in cancer development.

FDG PET/CT can improve cancer treatment plans in dogs.

Non-coding RNAs may be key in diagnosing and treating rare skin disorders.

Understanding patients' emotions can help oncologists improve communication and support during treatment decisions.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

NIPT can help detect potential maternal cancer, and GIPXplore can identify immune diseases in pregnancies.

CRISPR-based tools improve understanding and treatment of skin development and conditions.

The study identified key genes and pathways linked to hair disorders, aiding precision medicine.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Certain genes and proteins may help diagnose and treat primary cicatricial alopecia.

Multiphoton microscopy can effectively assess breast cancer treatment responses without labels.

The Hedgehog signaling pathway is linked to cancer development, and targeting it with inhibitors shows promise but faces challenges like resistance.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.